Literature DB >> 8136295

Nuclear accessory factors enhance the binding of progesterone receptor to specific target DNA.

P Prendergast1, S A Oñate, K Christensen, D P Edwards.   

Abstract

The human progesterone receptor (PR) is dependent upon hormone and a nuclear accessory factor(s) for maximal binding to progesterone response elements (PRES) in vitro. Recombinant full-length PR, expressed in a baculovirus system and purified to apparent homogeneity, was used as a substrate to isolate and identify the accessory factor(s). The major PRE binding enhancement activity present in nuclear extracts was shown to be associated with the high mobility group chromatin protein HMG-1. Moreover, HMG-1 was equally effective in enhancing the DNA binding of both the A and B isoforms of PR. Enhancement of PRE binding was highly selective for HMG-1 as a single purified protein and was not mimicked by a general protein stabilization effect. In gel mobility shift assays, it appeared that HMG-1 enhanced PRE binding without stably participating as a component of the final DNA-PR complex, suggesting that HMG-1 acts indirectly by modifying the PR protein or the target DNA. HMG-1 is a sequence-independent DNA binding protein that recognizes distorted DNA structures and is also able to promote further distortions by bending DNA. Enhancement of PRE binding was found to be intrinsic to the conserved DNA binding domain of HMG-1 suggesting that HMG-1 acts by promoting a structural alteration in the target PRE-DNA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8136295     DOI: 10.1016/0960-0760(94)90245-3

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  11 in total

Review 1.  HMGB1 release by inflammasomes.

Authors:  Lieselotte Vande Walle; Thirumala-Dev Kanneganti; Mohamed Lamkanfi
Journal:  Virulence       Date:  2011-03-01       Impact factor: 5.882

2.  Neuropeptide modulators of high mobility group box 1 secretion as potential therapeutic agents for severe sepsis.

Authors:  Mitchell P Fink
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

3.  Progesterone regulation of tissue factor depends on MEK1/2 activation and requires the proline-rich site on progesterone receptor.

Authors:  Maria Loreto Bravo; Mauricio P Pinto; Ibeth Gonzalez; Barbara Oliva; Sumie Kato; Mauricio A Cuello; Carol A Lange; Gareth I Owen
Journal:  Endocrine       Date:  2014-05-23       Impact factor: 3.633

Review 4.  HMGB1 in hormone-related cancer: a potential therapeutic target.

Authors:  Madhuwanti Srinivasan; Souresh Banerjee; Allison Palmer; Guoxing Zheng; Aoshuang Chen; Maarten C Bosland; André Kajdacsy-Balla; Ramaswamy Kalyanasundaram; Gnanasekar Munirathinam
Journal:  Horm Cancer       Date:  2014-04-10       Impact factor: 3.869

Review 5.  Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke.

Authors:  Kazuhide Hayakawa; Jianhua Qiu; Eng H Lo
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

6.  Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance.

Authors:  Rajesh K Aneja; Allan Tsung; Hanna Sjodin; Julia V Gefter; Russell L Delude; Timothy R Billiar; Mitchell P Fink
Journal:  J Leukoc Biol       Date:  2008-08-07       Impact factor: 4.962

Review 7.  High-mobility group box 1: an amplifier of stem and progenitor cell activity after stroke.

Authors:  Kazuhide Hayakawa; Loc-Duyen D Pham; Ken Arai; Eng H Lo
Journal:  Acta Neurochir Suppl       Date:  2013

8.  High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells.

Authors:  V Boonyaratanakornkit; V Melvin; P Prendergast; M Altmann; L Ronfani; M E Bianchi; L Taraseviciene; S K Nordeen; E A Allegretto; D P Edwards
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

9.  Estrogen receptor accessory proteins: effects on receptor-DNA interactions.

Authors:  C C Landel; P J Kushner; G L Greene
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

10.  Bench-to-bedside review: High-mobility group box 1 and critical illness.

Authors:  Mitchell P Fink
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.